Population Pharmacokinetic Analysis of Lanreotide Autogel® in Healthy Subjects

Clinical Pharmacokinetics - United Kingdom
doi 10.2165/0003088-200948010-00004
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Population Pharmacokinetic Analysis of Cilostazol in Healthy Subjects With Genetic Polymorphisms of CYP3A5, CYP2C19 andABCB1

British Journal of Clinical Pharmacology
Pharmacology
2010English

Population Pharmacokinetic Modeling and Simulation of Fremanezumab in Healthy Subjects and Patients With Migraine

British Journal of Clinical Pharmacology
Pharmacology
2019English

Pharmacokinetic Profile of Lesogaberan (AZD3355) in Healthy Subjects

Drugs in R and D
Pharmacology
2011English

Population Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling of Depot Testosterone Cypionate in Healthy Male Subjects

English

Efficacy of the New Long-Acting Formulation of Lanreotide (Lanreotide Autogel) in Somatostatin Analogue-Naive Patients With Acromegaly

Journal of Endocrinological Investigation
EndocrinologyMetabolismDiabetes
2009English

Pharmacokinetic Study of Frusemide in Healthy and Cirrhotic Indian Subjects

Internet Journal of Medical Update
Medicine
2008English

A Population Pharmacokinetic Analysis of Dextroamphetamine in the Plasma and Hair of Healthy Adults

Clinical Drug Investigation
MedicinePharmacology
2015English

Population Pharmacokinetic-Pharmacodynamic Modeling of Captopril in Healthy Volunteers

Journal of Korean Society for Clinical Pharmacology and Therapeutics
2001English

Mechanistic Pharmacokinetic Modelling of Ephedrine, Norephedrine and Caffeine in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy